论文期刊

取消

高级检索

检索历史清除

首页> Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin> A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

导出 OA

翻译打印收藏纠错

作者： Vivian D,Hope ^[1] ; Ross J,Harris ^[2] ; Peter,Vickerman ^[2] ; Lucy,Platt ^[3] ; Justin,Shute ^[4] ; Katelyn J,Cullen ^[2] ; Samreen,Ijaz ^[2] ; Sema,Mandal ^[2] ; Fortune,Ncube ^[5] ; Monica,Desai ^[2] ; John V,Parry ^[5]

作者单位： Public Health Institute, Liverpool John Moores University, Liverpool, United Kingdom. ^[1] National Infection Service, Public Health England, London, United Kingdom. ^[2] University of Bristol, Bristol, United Kingdom. ^[3] Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom. ^[4] The National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Blood Borne and Sexually Transmitted Infections at University College London, London, United Kingdom. ^[5]

关键词 hepatitis C incidence intervention impact monitoring people who inject drugs

主题词成年人(Adult);横断面研究(Cross-Sectional Studies);英格兰(England);女(雌)性(Female);肝炎病毒属(Hepacivirus);丙型肝炎(Hepatitis C);丙型肝炎抗体(Hepatitis C Antibodies);人类(Humans);发病率(Incidence);男(雄)性(Male);中年人(Middle Aged);北爱尔兰(Northern Ireland);患病率(Prevalence);RNA, 病毒(RNA, Viral);物质滥用, 静脉内(Substance Abuse, Intravenous);威尔士(Wales)

DOI 10.2807/1560-7917.ES.2018.23.47.1700635

PMID 30482265

发布时间 2022-12-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Euro surveillance

2018年23卷47期

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷